Herencia-Ropero, Andrea
Llop-Guevara, Alba
Staniszewska, Anna D.
Domènech-Vivó, Joanna
García-Galea, Eduardo
Moles-Fernández, Alejandro
Pedretti, Flaminia
Domènech, Heura
Rodríguez, Olga
Guzmán, Marta
Arenas, Enrique J.
Verdaguer, Helena
Calero-Nieto, Fernando J.
Talbot, Sara
Tobalina, Luis
Leo, Elisabetta
Lau, Alan
Nuciforo, Paolo
Dienstmann, Rodrigo
Macarulla, Teresa
Arribas, Joaquín
Díez, Orland
Gutiérrez-Enríquez, Sara
Forment, Josep V.
O’Connor, Mark J.
Albertella, Mark
Balmaña, Judith
Serra, Violeta http://orcid.org/0000-0001-6620-1065
Funding for this research was provided by:
GHD-Pink program
Fundación Fero
Departament d'Empresa i Coneixement, Generalitat de Catalunya (2021 SGR 1510, 2021 SGR 01112)
Instituto de Salud Carlos III (PI20/00892, CPII19/00033, PI19/01303, PI22/01200)
Fundación Científica Asociación Española Contra el Cáncer (INVES20095LLOP, POSTD211413AREN)
PERIS - Departament de Salut, Generalitat de Catalunya (SLT017/20/000081)
La Caixa Foundation (LCF/BQ/DI19/11730051 (ID 100010434)
Departament de Salut, Generalitat de Catalunya (AGAUR 2020 FI-B 00584, PERIS SLT028/23/000310)
Ministerio de Ciencia, Innovación y Universidades (PRE2021-099087)
Article History
Received: 13 February 2024
Accepted: 26 July 2024
First Online: 26 August 2024
Declarations
:
: Fresh tumor samples from cancer patients were collected for implantation into nude mice under a protocol approved by the Ethics Committee for Clinical Research (PR(AG)484/2017) and an associated written informed consent. Procedures involving human specimens were conducted according to the principles of the Helsinki Declaration. Experiments were conducted following the European Union’s animal care directive (2010/63/EU) and were approved by the Ethical Committee of Animal Experimentation of the Vall d’Hebron Research Institute. All patients provided written informed consent to participate in the study.
: Not applicable.
: ALG, VS, and JB are co-inventors of a patent related to this work (WO2019122411A1). We report research grants from AstraZeneca (VS) and personal fees and/or nonfinancial support from AstraZeneca (JB, VS), Pfizer (JB), and GSK (VS). ADS, FJCN, ST, LT, EL, AL, ALG, JF, MJOC, and MA are full time-time employees and shareholders at AZ. The remaining authors declare that they have no competing interests. The PARPi and ATRi used in this study were provided by AstraZeneca.